Trial Profile
A Phase IIb clinical trial of SYNB1020 in patients with liver cirrhosis with elevated blood ammonia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Jan 2018
Price :
$35
*
At a glance
- Drugs SYNB 1020 (Primary)
- Indications Hyperammonaemia
- Focus Adverse reactions
- 29 Jan 2018 New trial record